ALX Oncology enters $150M at-the-market stock offering agreement

ALX ONCOLOGY HOLDINGS INC

Entered Sales Agreement with Cantor Fitzgerald and Credit Suisse for ATM offering of up to $150M in common stock.
Sales may be made at-the-market on Nasdaq or in negotiated transactions; company sets parameters per placement notice.
Sales Agents receive 3.0% commission per share sold; company not obligated to sell any shares.
Offering made under existing S-3 shelf registration (filed August 2021); prospectus supplement filed December 17, 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.